Ricerca avanzata

Home > Riviste > The Journal of Cardiovascular Surgery > Fascicoli precedenti > The Journal of Cardiovascular Surgery 2010 Agosto;51(4) > The Journal of Cardiovascular Surgery 2010 Agosto;51(4):515-31

FASCICOLI E ARTICOLI   I PIÙ LETTI   eTOC

ULTIMO FASCICOLOTHE JOURNAL OF CARDIOVASCULAR SURGERY

Rivista di Chirurgia Cardiaca, Vascolare e Toracica

Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,632

Periodicità: Bimestrale

ISSN 0021-9509

Online ISSN 1827-191X

 

The Journal of Cardiovascular Surgery 2010 Agosto;51(4):515-31

NEW RESULTS IN THE ENDOVASCULAR MANAGEMENT OF ABDOMINAL AORTIC ANEURYSMS 

 REVIEW

Device-specific outcomes after endovascular abdominal aortic aneurysm repair

Bastos Goncalves F., Rouwet Ellen V., Metz R., Hendriks J. M., Vrancken Peeters M.-P. F. M., Muhs B. E., Verhagen H. J. M.

1 Department of Vascular Surgery, Erasmus University Medical Centre, Rotterdam, the Netherlands;
2 Department of Angiology and Vascular Surgery, Hospital de Santa Marta ,CHLC, RLisbon, Portugal;
3 Department of Surgery and Radiology, Yale University School of Medicine, New Haven, CT, USA

Over the last decade, endovascular aneurysm repair (EVAR) has been used extensively for the elective treatment of infra-renal abdominal aneurysms. However, it remains unclear how specific devices perform and how they compare to others. We provide an overview of currently used endografts, and discuss the current evidence regarding device-specific outcomes. Published literature confirms differences in results according to endograft selection. These differences were more pronounced with older generations of devices, in comparison to newer models. Contemporary results are generally good and one should remember that no randomized data exist regarding individual device performance. Moreover, by the time there is enough follow-up to draw conclusions, the data is relatively obsolete due to constant improvements in endograft technology and design. Results from EVAR have been steadily improving and individualized device selection has shown to be valuable. It appears that patients with favorable anatomy do well with most modern endografts. Those with challenging anatomies may benefit more from a particular design, delivery and deployment feature requiring greater knowledge and experience for adequate device selection.

lingua: Inglese


FULL TEXT  ESTRATTI

inizio pagina